ProfileGDS5678 / 1431845_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 52% 52% 52% 50% 52% 54% 54% 52% 51% 52% 52% 52% 53% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3183452
GSM967853U87-EV human glioblastoma xenograft - Control 23.2625352
GSM967854U87-EV human glioblastoma xenograft - Control 33.2659852
GSM967855U87-EV human glioblastoma xenograft - Control 43.1354650
GSM967856U87-EV human glioblastoma xenograft - Control 53.2038452
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.4465254
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4193854
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2441152
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.226651
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.248852
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2455252
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2300552
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.3223553
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.254352